发明名称
摘要 A method of predicting clinical outcome for a human subject diagnosed with colorectal cancer following surgical resection of said cancer is disclosed. A normalized expression level is determined of an RNA transcript of MYBL2, or an expression product thereof, in a biological sample comprising cancer cells obtained from said human subject. The likelihood of a positive clinical outcome for said human subject is then predicted based on said normalized expression level, wherein normalized expression of an RNA transcript of MYBL2, or an expression product thereof, is positively correlated with an increased likelihood of a positive clinical outcome.
申请公布号 JP2009523028(A) 申请公布日期 2009.06.18
申请号 JP20080550454 申请日期 2007.01.11
申请人 发明人
分类号 C12Q1/68;C12N15/09;C12Q1/02 主分类号 C12Q1/68
代理机构 代理人
主权项
地址